Advanced search
Publication Cover
Journal of Neurogenetics Volume 18, 2004 - Issue 2
Submit an article Journal homepage
569
Views
31
CrossRef citations to date
0
Altmetric
Research Article

VEGF PROMOTER HAPLOTYPE AND AMYOTROPHIC LATERAL SCLEROSIS (ALS)

PAUL D. TERRYCorrespondence[email protected]
,
FREYA KAMEL Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, NC, 27709
,
DAVID M. UMBACH Biostatistics Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, NC, 27709
,
TERESA A. LEHMAN BioServe Biotechnologies Ltd., Laurel, MD, 20707
,
HOWARD HU Harvard School of Public Health and Harvard Medical School, Boston, MA
,
DALE P. SANDLER Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, NC, 27709
&
JACK A. TAYLOR
 show all
Pages 429-434 | Published online: 11 Jul 2009

REFERENCES

  • Azzouz M., Ralph G.S., Storkebaum E., Walmsley L.E., Mitrophanous K.A., Kingsman S.M., Carmeliet P., Mazarakis N.D.. 2004. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature. 429: 413–417. [PUBMED], [INFOTRIEVE]
  • Breslow N., Day N.. 1980; Statistical Methods in Cancer Research: Analysis of Case Control Studies. LyonFrance, IARC
  • Brooks B.R.. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial. 1994, Clinical limits of amyotrophic lateral sclerosis (workshop contributors). J. Neurol. Sci.. 124(Suppl.)96–107. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Devos D., Moreau C., Lassalle P., Perez T., De Seze J., Brunaud-Danel V., Destee A., Tonnel A.B., Just N.. 2004. Low levels of the vascular endothelial growth factor in CSF from early ALS patients. Neurology. 62: 2127–2129. [PUBMED], [INFOTRIEVE]
  • Cleveland J.L.. 2003. A new piece of the ALS puzzle. Nat. Genet.. 34: 357–358. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Greenberg D.A., Jin K.. 2004. VEGF and ALS: the luckiest growth factor?. Trends Molec. Med.. 10: 1–3. [CSA], [CROSSREF]
  • Kamel F., Umbach D.M., Lehman T.A., Park L.P., Munsat T.L., Shefner J.M., Sandler D.P., Hu H., Taylor J.A.. 2003. Amyotrophic lateral sclerosis, lead, and genetic susceptibility: polymorphisms in the delta-aminolevulinic acid dehydratase and vitamin D receptor genes. Environ. Health Perspect.. 111: 1335–1339. [PUBMED], [INFOTRIEVE], [CSA]
  • Kamel F., Umbach D.M., Munsat T.L., Shefner J.M., Hu H., Sandler D.P.. 1999. Lead exposure and amyotrophic lateral sclerosis. Epidemiology. 13: 311–319
  • Kamel F., Umbach D.M., Munsat T.L., Shefner J.M., Sandler D.P.. 1999. Association of cigarette smoking with amyotrophic lateral sclerosis. Neuroepidemiology. 18: 194–202. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Lambrechts D., Storkebaum E., Morimoto M., Del-Favero J., Desmet F., Marklund S.L., Wyns S., Thijs V., Andersson J., van Marion I., Al-Chalabi A., Bornes S., Musson R., Hansen V., Beckman L., Adolfssan R., Pall H.S., Prats H., Vermeire S., Rutgeerts P., Katayama S., Awata T., Leigh N., Lang-Lazdunski L., Dewerchin M., Shaw C., Moons L., Vlietinck R., Morrison K.E., Robberecht W., Van Broeckhoven C., Collen D., Andersen P.M., Carmeliet P.. 2003. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet.. 34: 383–394. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K, Van Dorpe J., Hellings P., Gorselink M., Heymans S., Theilmeier G., Dewerchin M., Laudenbach V., Vermylen P., Raat H., Acker T., Vleminckx V., Van Den Bosch L., Cashman N., Fujisawa H., Drost M.R., Sciot R., Bruyninckx F., Hicklin D.J., Ince C., Gressens P., Lupu F., Plate K.H., Robberecht W., Herbert J.M., Collen D., Carmeliet P.. 2001. Deletion of the hypoxiaresponse element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet.. 28: 131–138. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Storm N., Darnhofer-Patel B., van den Boom D., Rodi C.P.. 2003. MALDI-TOF mass spectrometry-based SNP genotyping. Meth. Molec. Biol.. 212: 241–262. [CSA]
  • Strong M., Rosenfeld J.. 2003. Amyotrophic lateral sclerosis: a review of current concepts. Amyotroph Lateral Scler, Other Motor Neuron Disord. 4: 136–143. [CSA], [CROSSREF]
  • Weir B.. 1996; Genetic Data Analysis II. Sunderland, MA, Sinauer Associates

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.